Add to my selection

SARCLISA (isatuximab)

Medicine - Posted on Jan 10 2022

Active substance (DCI)

isatuximab

history (2)

10/20/21

SARCLISA (isatuximab) (myélome multiple)

Key points Favourable opinion for reimbursement in combination with carfilzomib and dexamethasone, for the treatment of adul...

CAV :
54321

icône flèche
11/18/20

SARCLISA (isatuximab)

Key points Favourable opinion for reimbursement in combination with pomalidomide and dexamethasone, for the treatment of adu...

CAV :
54321

icône flèche

Technical information

ATC code

L01XC38

Manufacturer

SANOFI-AVENTIS FRANCE

Presentation

SARCLISA 20 mg/ml, solution à diluer pour perfusion
1 flacon en verre de 5 ml - (Code CIP : 34009 550 740 4 5)
1 flacon en verre de 25 ml - (Code CIP : 34009 550 740 6 9)

All our publications

Drug therapy

Hematologic cancers

My account

You do not have a saved search

No element in selection

SARCLISA (isatuximab)

SARCLISA (isatuximab) (myélome multiple)

SARCLISA (isatuximab)

Follow us :